SPECT, PET and CT angiography results were not leading to therapeutic changes in the patients receiving them.
The most accurate of radiologic scans is wasted if it doesn’t lead to appropriate care. A study published January 31 in the Journal of the American College of Cardiology found that patients at high risk of coronary artery disease gained only marginally from noninvasive imaging. Why? Because SPECT, PET and CT angiography results were not leading to therapeutic changes in the patients receiving them.
Using data from 1,703 patients in the Study of Myocardial Perfusion and Coronary Anatomy Imaging Roles in CAD (SPARC), lead author Marcelo Di Carli, MD, of Brigham & Women's Hospital in Boston, and colleagues assessed the rates of catheterization and medication changes 90 days after patients had undergone cardiac single-photon emission computed tomography (SPECT), positron emission tomography (PET), or 64-slice coronary computed tomography angiography (CT angiography). The patients had no documented history of coronary artery disease, but an intermediate to high likelihood of having heart disease.
At 90 days, 9.6 percent of patients underwent catheterization. But among patients with the most severe test result findings, 38 percent to 61 percent were not referred to catheterization, 20 percent to 30 percent were not receiving aspirin, 35 percent to 44 percent were not receiving a beta-blocker, and 20 percent to 25 percent were not receiving a lipid-lowering agent.
Compared with stress SPECT or PET, changes in aspirin and lipid-lowering agent use was greater after CT angiography, as was the 90-day catheterization referral rate for normal/nonobstructive and mildly abnormal test results.
Although cardiac catheterization and medical therapy increased in proportion to the degree of abnormality in imaging results, the relatively low frequency of catheterization and medication change in the wake of radiology exams suggests possible undertreatment of higher risk patients, the researchers said.
“A noninvasive procedure, the results of which have no impact on subsequent management, must be considered an inappropriate study; the current study suggests that a significant amount of inappropriate noninvasive procedures are currently performed,” Di Carli and colleagues added.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.